BSEBoard Meeting2 Nov 2026 · 2 Nov 2026, 06:35 pm
Shanmuga Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2026 and Declaration of 1st interim dividend, if any, for the Financial Year 2026-27
Shanmuga Hospital Ltd · 544365
✦ AI SummaryResults
Shanmuga Hospital Ltd has scheduled a board meeting on 12/11/2026 to consider unaudited financial results for Q2 FY2026-27 and declare 1st interim dividend, if any.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shanmuga Hospital Ltd - 544365 - Board Meeting Intimation for Consideration Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2026 And Declaration Of 1St Interim Dividend, If Any, For The Financial Year 2026-27
Attachments (1)
📄pdf
Download →
90d1bfca-a03a-40dc-a263-d5811099c1cd.pdf
View document text
SHANMUGA HOSPITAL LIMITED
Formerly known as Shanmuga Hospital Private Limited
Reg. Off: 51/24, Saradha College Road, Salem—636 007.
CIN: L85110TZ2020PLC033974 | GSTIN: 33ABDCS8326A 1ZP
Tele: 0427-2706674 |E-mail: secretarial@shanmugahospital.com
Website: www.shanmugahospital.com
ISIN: INE0TD301017 | Symbol: SHANMUGA |Script Code: 544 365
SHL/SE/2026-27/39 02/11/2026
The Listing Department
BSE Limited
P. J. Towers, Dalal Street,
Mumbai-40000, Maharashtra
Scrip Code: 544365 | ISIN: INE0TD301017
SUB: Intimation of Board Meeting under Regulation 29(1)(a) of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015.
Dear Sir/ Madam,
Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015,
notice is hereby given that the meeting of the Board of Directors of Shanmuga Hospital Limited (“The
Company”) will be held on Thursday, November 12, 2026 to consider the following inter alia;
a. To Declare the Unaudited Financial Results of the Company for the quarter and half year ended
September 30, 2026
b. Declaration of 1st Interim dividend, if any, on the equity share capital of the Company for the
Financial Year 2026-27.
c. Any other business with the permission of the Chair.
Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance
with the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in
the securities of the Company is already closed with effect from October 01, 2026 and shall continue to
remain closed till 48 (forty-eight) hours after the declaration of the unaudited financial results of the
Company for the quarter and half year ended September 30, 2026.
This is for your information and records.
Thanking you
For Shanmuga Hospital Limited
Kannan Anjana Maragatham
Company Secretary & Compliance Officer
M. No. A70080
SECRE TARIAL DEPARTMENT
Comp liance Officer: CS Anjana Maragatham
E-Mail : cs@smrft.org